Bilan économique

Restrictive blood transfusion practices are associated with improved patient outcomes. (manokatra rohy)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Loharanon-kevitra‎: Transfusion 2014;54(10 Pt 2):2753-9.

Rakitra‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (manokatra rohy)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (manokatra rohy)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Loharanon-kevitra‎: Transfusion 2017;57(6):1347-58.

Rakitra‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (manokatra rohy)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (manokatra rohy)

MacLaren R, Sullivan PW.

Loharanon-kevitra‎: Value Health 2005;8(2):105-16.

Rakitra‎: PubMed 15804319

DOI‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (manokatra rohy)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (manokatra rohy)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Loharanon-kevitra‎: Transfusion 2015;55(12):2807-15.

Rakitra‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (manokatra rohy)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (manokatra rohy)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Loharanon-kevitra‎: Crit Care 2015;19:83.

Rakitra‎: PubMed 25880548

DOI‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (manokatra rohy)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (manokatra rohy)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Loharanon-kevitra‎: Health Technol Assess 2013;17(10):1-79.

Rakitra‎: PubMed 23477634

DOI‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (manokatra rohy)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (manokatra rohy)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Loharanon-kevitra‎: J Trauma 2009;66(1):63-72.

Rakitra‎: PubMed 19131807

DOI‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (manokatra rohy)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (manokatra rohy)

Zilberberg MD, Shorr AF.

Loharanon-kevitra‎: BMC Health Serv Res 2007;7:138.

Rakitra‎: PubMed 17764560

DOI‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (manokatra rohy)

SOINS INTENSIFS ET RÉANIMATION

Bilan économique

Malagasy

Bilan économique

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (manokatra rohy)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (manokatra rohy)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (manokatra rohy)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (manokatra rohy)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (manokatra rohy)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (manokatra rohy)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (manokatra rohy)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (manokatra rohy)

Tompon’andraikitra eo An-toerana

Fanazavana Momba ny Fitsaboana

Video

Bilan économique

Fidio ny Fiteninao

Hizara